The FDA has announced a withdrawal of all Propoxyphene products from the market due to serious risks of cardiac toxicity. This includes Darvon, Darvocet, and all generic versions. Health professionals have been instructed to cease prescribing and dispensing of these products. In addition the FDA has recommended that patients with prescriptions for propoxyphene products be contacted and asked to stop taking the medication. Outcome Resources clients may contact our clinical department and speak to a clinical pharmacist for appropriate guidance on alternative analgesic therapy.
AUDIENCE: Pain management, Pharmacy
ISSUE: FDA notified healthcare professionals that Xanodyne Pharmaceuticals has agreed to withdraw propoxyphene, an opioid pain reliever used to treat mild to moderate pain, from the U.S. market at the request of the FDA, due to new data showing that the drug can cause serious toxicity to the heart, even when used at therapeutic doses. FDA concluded that the safety risks of propoxyphene outweigh its benefits for pain relief at recommended doses. FDA requested that the generic manufacturers of propoxyphene-containing products remove their products as well.
BACKGROUND: FDA’s recommendation is based on all available data including data from a new study that evaluated the effects that increasing doses of propoxyphene have on the heart (see Data Summary in Drug Safety Communication). The results of the new study showed that when propoxyphene was taken at therapeutic doses, there were significant changes to the electrical activity of the heart: prolonged PR interval, widened QRS complex and prolonged QT interval. These changes can increase the risk for serious abnormal heart rhythms.
RECOMMENDATION: FDA recommends that healthcare professionals stop prescribing and dispensing propoxyphene-containing products to patients, contact patients currently taking propoxyphene-containing products and ask them to discontinue the drug, inform patients of the risks associated with propoxyphene, and discuss alternative pain management strategies. Patients were advised to dispose of unused propoxyphene in household trash by following the recommendations outlined in the Federal Drug Disposal Guidelines.
Read the MedWatch safety alert, including links to the Drug Safety Communication, News Release, and supporting documents, at:
|Superb content, my frined. You are truly a literary genius. This kind of article requires a great mind and a lot of research. I commend you on the hard work you put into this writing.
Posted 2/17/2013 01:19:37 AM
|I agree with almost ehirytveng you have to say except that insurance companies should reimburse therapists at the same rate as psychiatrists. A psychiatrist has completed four years of professional school plus at least four additional years of residency training after that. It's already difficult enough to recruit medical school graduates into fields like psychiatry that are not as well compensated as the procedure oriented fields. And it's even more difficult in psychiatry to incorporate psychotherapy into practice when you could fill that same hour with four fifteen minute med checks. So, to put the psychiatrist on the same billing level as someone who has spent considerably less time in training and has a lower debt level is a step backwards for the mental health field.
Posted 9/18/2012 02:57:16 PM
|First 10||<<Previous 10||Next 10 >>||Last 10|
Education Resources and Support for Hospices
Stay up-to-date on the latest hospice pharmacy benefits management information and tools with a variety of education resources and support at no extra charge. We offer presentations live at your facility, over the Internet or viateleconference, online service education programs, customized courses, and courses accredited for nursing continuing education credit.
Our palliative care experts provide clinical consulting on important medication management and care decisions. Our non-dispensing pharmacists provide focused attention and unbiased advice.
Why Use A PBM?
Contracting with multiple pharmacies, doing all the reporting, trying to stay current with medical practices and stay compliant while keeping costs down? There’s an easier and more effective way.